Home The Word Brain	My Amedeo FAQ Privacy About
	C49 In our changing world, speaking just English isn't enough. Open new doors with skills in another world language. Start with 7 words a day. Next week: +49.

Hepatitis

Free Subscription Articles published in Eur J Gastroenterol Hepatol Retrieve available abstracts of 37 articles: HTML format

Single Articles

May 2025
1. PAKUWAL E, Tan JL, Page AJ, Stringer AM, et al
   A systematic review and meta-analysis on the efficacy of fecal microbiome transplantation in patients with severe alcohol-associated hepatitis.
   Eur J Gastroenterol Hepatol. 2025 May 8. doi: 10.1097/MEG.0000000000003003.
   PubMed     Abstract available
   
   
   
2. HABIBI MA, Aghayee F, Mirjani MS, Karimifar MR, et al
   The safety and efficacy of rituximab in autoimmune hepatitis: a systematic review and quality assessment.
   Eur J Gastroenterol Hepatol. 2025 May 6. doi: 10.1097/MEG.0000000000002981.
   PubMed     Abstract available
   
   
   
3. CHEN J, Liu X, Guan C, Peng Y, et al
   Sterile systemic inflammation reaction associated with 90-day mortality in patients with HBV-related acute-on-chronic liver failure.
   Eur J Gastroenterol Hepatol. 2025;37:644-651.
   PubMed     Abstract available
   
   
   March 2025
4. GARCIA-HEROLA A, Sanchez-Reyes MS, Gomez-Escolar L, Llobregat L, et al
   Efficiency of opportunistic population screening in a gastrointestinal endoscopy unit as a hepatitis C elimination strategy.
   Eur J Gastroenterol Hepatol. 2025 Mar 26. doi: 10.1097/MEG.0000000000002973.
   PubMed     Abstract available
   
   
   
5. LIU T, Gu J
   A cross-sectional study investigating knowledge, attitudes, and practices of the general population regarding early diagnosis and treatment of hepatitis.
   Eur J Gastroenterol Hepatol. 2025 Mar 4. doi: 10.1097/MEG.0000000000002957.
   PubMed     Abstract available
   
   
   February 2025
6. HE Q, Chen Z, Deng Y, Mao C, et al
   Plasma microRNA-30a expression in patients with chronic hepatitis B and its application value in the assessment of the severity of liver fibrosis.
   Eur J Gastroenterol Hepatol. 2025 Feb 18. doi: 10.1097/MEG.0000000000002918.
   PubMed     Abstract available
   
   
   
7. LIU T, Shi Y, Wu J, Qin L, et al
   Predictive value of serum HBV RNA on HBeAg seroconversion in treated chronic hepatitis B patients.
   Eur J Gastroenterol Hepatol. 2025 Feb 11. doi: 10.1097/MEG.0000000000002946.
   PubMed     Abstract available
   
   
   
8. DOS SANTOS DM, Penteado JO, Nader MM, Basso RP, et al
   Analysis of noninvasive methods in chronic hepatitis/human immunodeficiency virus mono- and co-infected patients with advanced fibrosis.
   Eur J Gastroenterol Hepatol. 2025 Feb 6. doi: 10.1097/MEG.0000000000002936.
   PubMed     Abstract available
   
   
   January 2025
9. EL-KASSAS M, Barakat EMF, Shousha HI, Kohla M, et al
   Characteristics and survival of patients with viral versus nonviral associated hepatocellular carcinoma: a multicenter cohort study.
   Eur J Gastroenterol Hepatol. 2025;37:83-93.
   PubMed     Abstract available
   
   
   
10. ALHALABI MM, Almokdad R
    The incidence of hepatitis B reactivation in patients receiving ustekinumab: a systematic review and proportional meta-analysis.
    Eur J Gastroenterol Hepatol. 2025;37:1-9.
    PubMed     Abstract available
    
    
    December 2024
11. 
    The Primary Cause of Markedly Elevated Aminotransferases in Hospitalized Patients with Cirrhosis in Ischemic Hepatitis: Erratum.
    Eur J Gastroenterol Hepatol. 2024;36:1472.
    PubMed    
    
    
    November 2024
12. ZHANG J, Lin Y, Zhu Y
    Recompensation features and prognosis in hepatitis B virus-related acute-on-chronic liver failure patients.
    Eur J Gastroenterol Hepatol. 2024 Nov 14. doi: 10.1097/MEG.0000000000002891.
    PubMed     Abstract available
    
    
    
13. ZHANG S, Zhou T, Wu M, Xiong X, et al
    Sarcopenia is associated with new-onset acute biliary infection within 1 year in patients with hepatitis B virus-related decompensated cirrhosis.
    Eur J Gastroenterol Hepatol. 2024 Nov 8. doi: 10.1097/MEG.0000000000002875.
    PubMed     Abstract available
    
    
    
14. ALLAM J, Ibrahim A, Rockey DC
    The primary cause of markedly elevated aminotransferases in hospitalized patients with cirrhosis in ischemic hepatitis.
    Eur J Gastroenterol Hepatol. 2024;36:1346-1351.
    PubMed     Abstract available
    
    
    October 2024
15. GIORGIO M, Ramirez Ladino KA, Lopez G, Sosa Rojas M, et al
    Frequency of hepatitis D virus with different hepatitis B virus serological markers and coinfections in hospital patients from Argentina: synchronous testing of anti-HDV antibodies and HDV RNA.
    Eur J Gastroenterol Hepatol. 2024 Oct 8. doi: 10.1097/MEG.0000000000002857.
    PubMed     Abstract available
    
    
    September 2024
16. ALLAM J, Ibrahim A, Rockey DC
    The primary cause of markedly elevated aminotransferases in hospitalized patients with cirrhosis in ischemic hepatitis.
    Eur J Gastroenterol Hepatol. 2024 Sep 23. doi: 10.1097/MEG.0000000000002855.
    PubMed     Abstract available
    
    
    July 2024
17. ZHANG Y, Lin X, Wu H, Chen J, et al
    Systematic review with network meta-analysis: sustained hepatitis B surface antigen clearance after pegylated interferon cessation.
    Eur J Gastroenterol Hepatol. 2024 Jul 22. doi: 10.1097/MEG.0000000000002823.
    PubMed     Abstract available
    
    
    
18. DANIELSSON O, Vesterinen T, Arola J, Aberg F, et al
    Coexistence of metabolic-associated fatty liver disease and autoimmune or toxic liver disease.
    Eur J Gastroenterol Hepatol. 2024;36:961-969.
    PubMed     Abstract available
    
    
    June 2024
19. WANG FC, Dong Y, Xu ZQ, Gao YJ, et al
    Characteristics analysis of hepatitis B core-related antigen in children with hepatitis B e antigen-positive chronic viral hepatitis B infection.
    Eur J Gastroenterol Hepatol. 2024 Jun 28. doi: 10.1097/MEG.0000000000002812.
    PubMed     Abstract available
    
    
    
20. LIN CY, Sun WC, Lu CM, Chen WC, et al
    Entecavir vs. tenofovir disoproxil fumarate in the treatment of chronic hepatitis B patients with severe acute exacerbation.
    Eur J Gastroenterol Hepatol. 2024 Jun 26. doi: 10.1097/MEG.0000000000002709.
    PubMed     Abstract available
    
    
    
21. XU J, Tan L, Jiang N, Li F, et al
    Assessment of nomogram model for the prediction of esophageal variceal hemorrhage in hepatitis B-induced hepatic cirrhosis.
    Eur J Gastroenterol Hepatol. 2024;36:758-765.
    PubMed     Abstract available
    
    
    
22. CADRANEL JD, Zougmore HT, Efole JN, Hanslik B, et al
    Hepatitis B Delta: assessment of the knowledge and practices of hepato-gastroenterologists practicing in non-academic settings in France.
    Eur J Gastroenterol Hepatol. 2024;36:735-741.
    PubMed     Abstract available
    
    
    May 2024
23. VUKOVIC MN, Jaksic M, Stojanovic D, Smolovic B, et al
    Time trends in liver cancer mortality rates in Montenegro from 1990 to 2018.
    Eur J Gastroenterol Hepatol. 2024;36:622-627.
    PubMed     Abstract available
    
    
    
24. PEPPAS S, Doumas S, Suvarnakar A, Chou J, et al
    Clinical outcomes with metformin use in diabetic patients with compensated cirrhosis: a systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2024;36:674-682.
    PubMed     Abstract available
    
    
    April 2024
25. MACIEL AMA, Ferraz MLCG, Perez RM, Brandao-Mello CE, et al
    Renal dysfunction during treatment of chronic hepatitis B with tenofovir disoproxyl fumarate and associated risk factors.
    Eur J Gastroenterol Hepatol. 2024;36:482-488.
    PubMed     Abstract available
    
    
    
26. ARSLAN E, Yildiz Y, Karasahin O, Demir Y, et al
    Evaluation of chronic hepatitis B patients who voluntarily discontinued oral antiviral therapy: is there an answer to the controversial topic?
    Eur J Gastroenterol Hepatol. 2024;36:438-444.
    PubMed     Abstract available
    
    
    
27. KOROGLU M, Ayvaz MA, Bakan SB, Sirin A, et al
    Can quantitative surface antigen levels and systemic immune-inflammation index be predictive as a new indicator for the initiation of treatment in chronic hepatitis b?
    Eur J Gastroenterol Hepatol. 2024;36:489-497.
    PubMed     Abstract available
    
    
    March 2024
28. HATOUM S, Rockey DC
    Long-term outcomes of patients with autoimmune hepatitis induced cirrhosis after immunosuppressive treatment.
    Eur J Gastroenterol Hepatol. 2024 Mar 28. doi: 10.1097/MEG.0000000000002714.
    PubMed     Abstract available
    
    
    
29. YUKSEKYAYLA O, Kina N, Ulaba A, Emin Ergun M, et al
    The frequency and clinical significance of antibodies to soluble liver antigen/liver pancreas in autoimmune hepatitis: a prospective single-center study.
    Eur J Gastroenterol Hepatol. 2024 Mar 4. doi: 10.1097/MEG.0000000000002747.
    PubMed     Abstract available
    
    
    
30. LAI X, Chen H, Dong X, Zhou G, et al
    AST to ALT ratio as a prospective risk predictor for liver cirrhosis in patients with chronic HBV infection.
    Eur J Gastroenterol Hepatol. 2024;36:338-344.
    PubMed     Abstract available
    
    
    
31. ARYAN M, Qian S, Chen Z, Louissaint J, et al
    Patients with early-stage alcohol-associated liver disease are at increased risk of hospital readmission and death.
    Eur J Gastroenterol Hepatol. 2024;36:318-325.
    PubMed     Abstract available
    
    
    February 2024
32. ABDULLAYEVA M, Celik M, Kuruuzum Z
    The performance of hepatitis B surface antigen quantification as a noninvasive biomarker predicting liver injury and serum hepatitis B virus DNA level.
    Eur J Gastroenterol Hepatol. 2024;36:245-249.
    PubMed     Abstract available
    
    
    January 2024
33. BRUNNER N, Grischott T, Bruggmann P
    Late presentation for hepatitis C treatment: prevalence and risk factors in the Swiss Hepatitis C Cohort.
    Eur J Gastroenterol Hepatol. 2024 Jan 22. doi: 10.1097/MEG.0000000000002705.
    PubMed     Abstract available
    
    
    November 2023
34. WANG X, Liu H, Wang P, Wang Y, et al
    A nomogram for analyzing risk factors of poor treatment response in patients with autoimmune hepatitis.
    Eur J Gastroenterol Hepatol. 2023 Nov 7. doi: 10.1097/MEG.0000000000002661.
    PubMed     Abstract available
    
    
    
35. UZEL A, Ebik B, Bucaktepe GE, Yolacan R, et al
    Do oral antiviral drugs used in the treatment of chronic hepatitis B cause erectile dysfunction?
    Eur J Gastroenterol Hepatol. 2023 Nov 7. doi: 10.1097/MEG.0000000000002672.
    PubMed     Abstract available
    
    
    
36. TSAI PS, Cheng YM, Wang CC, Kao JH, et al
    The impact of concomitant hepatitis C virus infection on liver and cardiovascular risks in patients with metabolic-associated fatty liver disease.
    Eur J Gastroenterol Hepatol. 2023;35:1278-1283.
    PubMed     Abstract available
    
    
    October 2023
37. OZDEN I, Kinaci E, Ocak I, Colak M, et al
    Successful results of early nucleos(t)ide analogue treatment for liver transplantation candidates with severe acute hepatitis B infection.
    Eur J Gastroenterol Hepatol. 2023 Oct 6. doi: 10.1097/MEG.0000000000002655.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge.